Perspectives on the Evolution of Stem Cell Therapy for Heart Failure.

about

Perspectives on the Evolution of Stem Cell Therapy for Heart Failure.

Item

http://www.wikidata.org/entity/Q36437708

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Perspectives on the Evolution of Stem Cell Therapy for Heart Failure.

@ast

Perspectives on the Evolution of Stem Cell Therapy for Heart Failure.

@en

type

Item

label

Perspectives on the Evolution of Stem Cell Therapy for Heart Failure.

@ast

Perspectives on the Evolution of Stem Cell Therapy for Heart Failure.

@en

prefLabel

Perspectives on the Evolution of Stem Cell Therapy for Heart Failure.

@ast

Perspectives on the Evolution of Stem Cell Therapy for Heart Failure.

@en

P1476

Perspectives on the Evolution of Stem Cell Therapy for Heart Failure.

@en

P2093

Bryon Tompkins

http://www.w3.org/2001/XMLSchema#string

Joshua M Hare

http://www.w3.org/2001/XMLSchema#string

Wayne Balkan

http://www.w3.org/2001/XMLSchema#string

P2860

Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial.

Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells

Allogeneic Mesenchymal Stem Cells Restore Endothelial Function in Heart Failure by Stimulating Endothelial Progenitor Cells.

Comparative Efficacy of Intracoronary Allogeneic Mesenchymal Stem Cells and Cardiosphere-Derived Cells in Swine with Hibernating Myocardium.

Mesenchymal Stem Cells as a Biological Drug for Heart Disease: Where Are We With Cardiac Cell-Based Therapy?

Cardiac Stem Cell Hybrids Enhance Myocardial Repair.

Synergistic Effects of Combined Cell Therapy for Chronic Ischemic Cardiomyopathy

Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction

A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction.

P304

1838-1839

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EBIOM.2015.11.043

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

284812243

http://www.w3.org/2001/XMLSchema#string

P698

26844249

http://www.w3.org/2001/XMLSchema#string

P932

4703738

http://www.w3.org/2001/XMLSchema#string